Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

ClinicalTrials.gov ID: NCT01712074

Public ClinicalTrials.gov record NCT01712074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 1:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, 18-week, Placebo-controlled, Double-blind, Parallel Group Study Of The Safety And Efficacy Of Pf-05212377 (Sam-760) In Subjects With Mild-to-moderate Alzheimer's Disease With Existing Neuropsychiatric Symptoms On A Stable Daily Dose Of Donepezil

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate safety and efficacy of PF-05212377 in subjects with mild-to-moderate Alzheimer's Disease with existing neuropsychiatric symptoms on a stable dose of Donepezil. The 4-week run-in will minimize placebo effect. The 12-week treatment period is considered the minimum length necessary to reliably evaluate the effect PF-05212377 on cognition and and neuropsychiatric symptoms in this population. The 2-week washout will allow to monitor re-emergence of neuropsychiatric and cognitive symptoms.

Study identification

NCT ID
NCT01712074
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
186 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2012 (Type not available)
Primary completion
Sep 2015 (Actual)
Completion
Sep 2015 (Actual)
Last update posted
Mar 20, 2017

2012 – 2015

United States locations

U.S. sites
40
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
ATP Clinical Research, Inc Costa Mesa California 92626 —
Sun Valley Research Center Imperial California 92251 —
Desert Valley Research Rancho Mirage California 92270 —
RAA - Apex Aquisition, LLC Santa Ana California 92705 —
Geriatric and Adult Psychiatry LLC Hamden Connecticut 06518 —
Yale University New Haven Connecticut 06510 —
Yale-New Haven Hospital, Temple Radiology New Haven Connecticut 06510 —
Yale University School of Medicine, MRI Research Center (MRI) New Haven Connecticut 06520 —
Diagnostic Centers of America Boynton Beach Florida 33437 —
Meridien Research Brooksville Florida 34601 —
Quantum Laboratories Deerfield Beach Florida 33064 —
Brain Matters Research Inc Delray Beach Florida 33445 —
MD Clinical Hallandale Florida 33009 —
Compass Research LLC-North Clinic Leesburg Florida 34748 —
Medical Research Group of Central Florida Orange City Florida 32763 —
Premiere Research Institute West Palm Beach Florida 33407 —
Institute for Advanced Medical Research Alpharetta Georgia 30005 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
Columbus Research & Wellness Institute, Inc. Columbus Georgia 31904 —
Lake Charles Clinical Trials Lake Charles Louisiana 70629 —
Michigan State University East Lansing Michigan 48824 —
Metro Imaging (Imaging only) Creve Coeur Missouri 63141 —
Millennium Psychiatric Associates, LLC Creve Coeur Missouri 63141 —
Eastside Comprehensive Medical Center, LLC New York New York 10021 —
University of Rochester Medical Center AD-CARE Program | University of Rochester Medical Center Rochester New York 14620 —
University of Rochester Medical Center (MRI Imaging Only) Rochester New York 14642 —
Behavioral Medical Research of Staten Island Staten Island New York 10305 —
The Ohio State University (administrative offices only) Columbus Ohio 43212 —
The Ohio State University - 2050 Columbus Ohio 43221 —
Keystone Clinical Studies, LLC Norristown Pennsylvania 19403 —
Roper Hospital (Imaging Only) Charleston South Carolina 29401 —
Roper St. Francis Healthcare Charleston South Carolina 29401 —
Roper St. Francis Pharmacy (IP Shipment/Storage) Charleston South Carolina 29401 —
Neurology Clinic, P.C. Cordova Tennessee 38018 —
Senior Adults Speciality Research Inc. Austin Texas 78757 —
Grayline Clinical Drug Trials Wichita Falls Texas 76309 —
Clinical Neuroscience Research Assoc. d/b/a The Memory Clinic Bennington Vermont 05201 —
Dean Foundation for Health, Research and Education Middleton Wisconsin 53562 —
Cary J. Kohlenberg, MD, dba, IPC Research Waukesha Wisconsin 53188 —
Merrill Hills Manor Waukesha Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01712074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 20, 2017 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01712074 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →